For procurement managers and R&D scientists in the pharmaceutical sector, sourcing high-quality chiral intermediates is paramount. (S)-Ethyl 2-Hydroxy-4-phenylbutanoate (CAS 125639-64-7) stands out as a critical building block, particularly for developing therapeutics aimed at metabolic disorders like insulin resistance and hyperglycemia. Its role in synthesizing complex molecules such as benzothiophenes, benzofurans, and indoles makes it indispensable for many drug discovery programs. When looking to buy this essential chemical, understanding the landscape of suppliers and manufacturers is key to ensuring product integrity and supply chain stability.

When seeking to purchase (S)-Ethyl 2-Hydroxy-4-phenylbutanoate, the focus should be on purity and reliable sourcing. Typically specified with a purity of 98% or higher, this compound's optical purity is also a crucial factor for its effectiveness in stereoselective synthesis. Identifying manufacturers in regions like China, known for its robust chemical manufacturing capabilities, can offer competitive pricing without compromising quality. Engaging with a trusted chemical supplier means not just acquiring the material, but also securing a partner who understands the stringent requirements of pharmaceutical development.

The utility of (S)-Ethyl 2-Hydroxy-4-phenylbutanoate extends beyond its primary pharmaceutical applications. Its chiral nature and functional groups also lend themselves to innovative uses in specialized cosmetic ingredients. For any serious inquiry about obtaining this chemical, it is advisable to seek out suppliers who can provide comprehensive documentation, including Certificates of Analysis (CoA) and Safety Data Sheets (SDS). Furthermore, proactive communication with a chemical manufacturer regarding lead times, minimum order quantities, and payment terms is essential for efficient procurement. By focusing on these aspects, procurement professionals can ensure a smooth and successful acquisition process for this vital pharmaceutical intermediate.